Bard Ventralex Hernia Patch Lawsuit Alleges Mesh Incompatible with Human Tissue
According to allegations raised in a recent product liability lawsuit filed against C.R. Bard, complications following hernia repair surgery were caused by the unreasonably dangerous design of the Bard Ventralex patch, which the plaintiff indicates is incompatible with human tissue.
The complaint (PDF) was filed last month in the U.S. District Court for the Middle District of Florida by Thomas Feeney, who indicates that he suffered a negative immune response after surgery where a Bard Ventralex hernia patch was used.
Feeney indicates that the manufacturer failed to perform proper testing and research about the risks associated with the Bard Ventralex hernia patch before marketing it to the medical community, resulting in a large number of complications among recipients. The complaint indicates that Bard knew or should have known that the Ventralex patch was unreasonably harmful, yet continued to market the hernia repair mesh as safe and effective.
“The Product was made of materials which are biologically incompatible with human tissue and react negatively and sometimes dangerously with a large number of those on whom it is used,” the lawsuit states. “The scientific evidence Defendant knew or should have known of demonstrates that the mesh is incompatible with human tissue and often causes a negative immune response in patients implanted with the Product, including Plaintiff.”
Feeney presents charges of negligence, design defect, manufacturing defect, failure to warn, and breach of warranty.
Hernia Mesh Litigation
Feeney’s complaint is the latest in a growing stream of hernia mesh lawsuits filed in recent months against manufacturers of various different products, which have been linked to a large number of problems since they were introduced.
Similar allegations have been raised in many Atrium C-Qur mesh lawsuits filed in courts nationwide, each indicating that the manufacturer of that hernia patch also failed to investigate or review complaints involving failures and infections that may be caused by design problems.
Pronounced “Secure”, Atrium C-Qur mesh was approved by the FDA on March 2006, for use in hernia repair, chest wall reconstruction and to repair traumatic or surgical wounds. The patch is made of a polypropylene mesh, with an outer coating of gel made from 3 fatty acids, which plaintiffs allege caused severe infections, allergic reactions and other complications after Atrium C-Qur hernia repair.
Earlier this year an Ethicon Physiomesh recall was issued for another popular type of hernia repair mesh, with the manufacturer removing the patch from the market worldwide, after discovering a high number of complications and failing to identify the cause of the problems. While the actions was classified as a “market withdrawal” in the United States, Johnson & Johnson’s Ethicon subsidiary has indicated that it has no intentions of returning the product to the market and asked hospitals to return the product.
A number of individuals who experienced severe and painful complications in recent years are now pursuing Ethicon Physiomesh hernia patch lawsuit, alleging that the manufacturer failed to adequately tested and researched the product before marketing it. Several of the complaints suggest that the problems may stem from the use of materials that are not inert and that react to human tissues, causing infections and increasing the risk that the hernia mesh migrates from the implant site to other parts of the body. Claims also indicate the mesh fails to perform and can abrade human tissue.
The complaint filed by Feeney is one of only a handful of Bard Ventralex hernia lawsuits filed in recent months, but it is widely expected that additional cases will be filed in the future, as individuals learn that complications experienced following hernia repair may have been caused by the defective design of the mesh.
MartyMay 7, 2018 at 1:30 am
My friend had bard ventalex umbilical patch in 2013 and was immediately hospitalized again for infections, including c-diff. The pain never went away. He started to have unexplained dry eye and other unexplained symptoms. Then he developed a rash on his legs and trunk and was diagnosed with Leukemia. The diagnosis was set aside in place of a series of other auto-immune diseases. They performed a b[Show More]My friend had bard ventalex umbilical patch in 2013 and was immediately hospitalized again for infections, including c-diff. The pain never went away. He started to have unexplained dry eye and other unexplained symptoms. Then he developed a rash on his legs and trunk and was diagnosed with Leukemia. The diagnosis was set aside in place of a series of other auto-immune diseases. They performed a biopsy on his leg and wanted to biopsy both kidneys. Now they say he has Sjrongen's and Henoch-Schonlein purpura, because of the purpura and vasculitis. They put him on steroids and when his white cells continued to climb, they doubled the dose. We thought we found three possible surgeons to remove the rash, but two have failed to respond and one wants him to lose weight and get off the steroids first. The docs who installed the mesh say the mesh cannot be causing the auto-immune response, because the amount of steroids they are giving him would have killed him by now. Help!
"*" indicates required fields
More Top Stories
With thousands of Bard hernia mesh lawsuits pending in the federal court system, a fourth bellwether trial will be held in the spring, involving allegations that defects with Bard 3DMax caused painful and permanent injuries.
A Tepezza hearing loss lawsuit accuses the manufacturer of failing to warn doctors to conduct hearing tests, which could have helped a woman avoid permanent hearing damage.
A South Dakota man has filed one of the first gastroparesis lawsuits against Ozempic manufacturers, alleging that users have not been adequately warned about the risk of severe vomiting and long-term stomach side effects.